Clinical trials recruiting for IPMN, Pancreatic
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| HOP bundle | 1 |
Self-screener
Recruiting trials
- AI-Powered Precision Decision-Making for Pancreatic Diseases
- Advanced Therapies for Liver Metastases
- Biophotonic Nanoparticle-enabled Laser Blood Test for Early Detection of Pancreatic Cancer
- Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression
- Integration of Multiomics Markers for Invasive IPMNs Identification Through the Set-up of the INvasive Cyst bIomarkers Detection (INCITE) Consortium
- Intraductal Papillary Mucinous Neoplasm (IPMN) Database - A Tool to Predict Pancreatic Cancer
- Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)
Related conditions
Trials recruiting for IPMN, Pancreatic often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for IPMN, Pancreatic trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.